Corticosteroid treatment in severe COVID-19 pneumonia: two cases and literature review

Coronavirus disease 2019 (COVID-19) pneumonia, firstly reported in Wuhan, Hubei province, China, has rapidly spread around the world with high mortality rate among critically ill patients. The use of corticosteroids in COVID-19 remains a major controversy. Available evidences are inconclusive. Accor...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Jinghong, Xiong, Yali, Li, Hui, Qian, Yajun, Xu, Ying, Xu, Qingqing, Yan, Xin, Tang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2020
Materias:
Case Based Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247779/
https://www.ncbi.nlm.nih.gov/pubmed/32451729
http://dx.doi.org/10.1007/s10067-020-05172-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7247779/
https://www.ncbi.nlm.nih.gov/pubmed/32451729
http://dx.doi.org/10.1007/s10067-020-05172-7

Ejemplares similares